SEC Form 4 · accession 0001140361-16-078839
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis S. Waldman
Officer — Controller
Period of report
Aug 31, 2016
Accepted (ET)
Sep 2, 2016 · 5:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2016 | A | 26,250 | $1.29 | A | 26,250 | D | |
| Common Stock | Aug 31, 2016 | S | 23,162 | $19.00 | D | 3,088 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.29 | Aug 31, 2016 | M | 26,250 | D | — | Sep 11, 2017 | Common Stock | 26,250 | 0 | D |
Explanation of responses
- F1This option is fully vested and exercisable.